Expression of adhesion molecules and von Willebrand factor in human coronary artery endothelial cells incubated with differently modified hemoglobin solutions

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 25, Issue 1-2, 1997, Pages 211-225

  Simoni, Jan ^a   Simoni, Grace ^a   Lox, Charles D ^a   Prien, Samuel D ^a   Tran, Ruc ^a   Shires, G Tom ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINETRIPHOSPHATE; ANIMAL CELL CULTURE; ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; CELL MEMBRANES; CHEMICAL MODIFICATION; HEMOGLOBIN;

CONFLUENCE; GLUTATHIONE; HUMAN CORONARY ARTERY ENDOTHELIAL CELLS (HCAEC); INTRACELLULAR ADHESION MOLECULE (ICAM); INTRAMOLECULAR CROSSLINKING; VASCULAR CELL ADHESION MOLECULE (VCAM); VON WILLEBRAND FACTOR (VWF);

BLOOD SUBSTITUTES;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANTIBODY; BLOOD SUBSTITUTE; CELL ADHESION MOLECULE; ENDOTOXIN; GLUTARALDEHYDE; GLUTATHIONE; HEMOGLOBIN; HEMOGLOBIN DERIVATIVE; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ARTERY ENDOTHELIUM; ARTICLE; CELL CULTURE; CELL SURFACE; CHEMICAL MODIFICATION; CONTROLLED STUDY; CORONARY ARTERY; CROSS LINKING; CULTURE MEDIUM; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INFLAMMATION; OXYGEN TRANSPORT; RETICULOENDOTHELIAL SYSTEM;

EID: 0030978263     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199709118911     Document Type: Article

References (69)

1. Hess JR: Review of modified hemoglobin research at Letterman: attempts to delineate the toxicity of cell-free tetrameric hemoglobin. Artif Cells Blood Substit Immobil Biotechnol 23:277-89(1995).
2. Winslow RM: Blood substitutes - a moving target. Nature Med 1(11):1212-15(1995).
3. Zuck TF, Riess JG: Current status of injectable oxygen carriers. Crit Rev Clin Lab Sci 31:295-324(1994).
4. Marwick C: More than a trickle of interest in blood substitutes. JAMA 271:895(1994).
5. Macdonald VW, Winslow RM, Marini MA, Klinker MT: Coronary vasoconstrictor activity of purified and modified human hemoglobin. Biomater Artif Cells Artif Organs 18:236-82(1990).
6. Greenburg AG, Kim HW: Nitrosyl hemoglobin formation in-vivo after intravenous administration of a hemoglobin- based oxygen carrier in endotoxemic rats. Artif Cells Blood Substit Immobil Biotechnol 23:271-6(1995).
7. Feola M, Simoni J, Tran R, Canizaro PC: Mechanism of toxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs 16:217-26(1990).
8. Simoni J, Feola M, Canizaro PC: Generation of free oxygen radicals and toxicity of hemoglobin solutions. Biomater Artif Cells Artif Organs 18:189-202(1990).
9. Alayash AI: Hemoglobin-based blood substitutes: potential free radical toxicity. Free Rad Biol Med 16:137-8(1994).
10. Chang TMS (ed): Abstracts from the VI International Symposium on Blood Substitutes. Artif Cells Blood Substit Immobil Biotechnol 24:295-464(1996).
11. Simoni J, Simoni G, Lox CD, Feola M: Reaction of human endothelial cells to bovine hemoglobin solution and tumor necrosis factor. Artif Cells Blood Substit Immobil Biotechnol 22:777-87(1994).
12. Simoni J, Simoni G, Lox CD, McGunegle DE, Feola M: Cytokines and PAF release from human monocytes and macrophages: effect of hemoglobin and contaminants. Artif Cells Blood Substit Immobil Biotechnol 22:525-34(1994).
13. McFaul SJ, Bowman PD, Villa VM, Gutierrez-Ibanez MJ, Johnson M, Smith D: Hemoglobin stimulates mononuclear leukocytes to release interleukin-8 and tumor necrosis factor alpha. Blood 84:3175-81(1994).
14. Smith DJ, Winslow RM: Effects of extraerythrocytic hemoglobin and its components on mononuclear cell procoagulant activity. J Lab Clin Med 119:176-82(1992).
15. Kleber EE, Lynch SR, Skikne B, Torrance JD, Bothwell TH, Charlton RW: Erythrocytes catabolism in the inflammatory peritoneal monocyte. Br J Haematol 39:41-54(1978).
16. Deiss A: Iron metabolism in reticuloendothelial cells. Sem Hematol 20:81-90(1983).
17. Stremmel W, Riedel HD, Niederau C, Strohmeyer G: Pathogenesis of genetic haemochromatosis. Eur J Clin Invest 23:321-9(1993).
18. Balla G, Vercellotti GM, Muller-Eberhard U, Eaton J, Jacob HS: Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest 64:648-55(1991).
19. Balla J, Jacob HS, Balla G, Nath K, Eaton JW, Vercellotti GM: Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci USA 90: 9285-9(1993).
20. Motterlini R, Foresti R, Vandegriff K, Intaglietta M, Winslow RM: Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am J Physiol 269:H648-55(1995).
21. Benton LD, Khan M, Greco RS: Integrins, adhesion molecules and surgical research. Surg Gynecol Obstet 177:311-27(1993).
22. Winn RK, Sharar SR, Vedder NB, Harlan JM: Leukocyte and endothelial adhesion molecules in ischaemia/reperfusion injuries. In: Marsh J, Goode JA (eds) Cell Adhesion and Human Disease, Chichester, England, John Wiley & Sons Ltd, 1995, pp 63-78.
23. Smith CW: Transendothelial migration. In: Harlan JM, Liu DY (eds) Adhesion: Its Role In Inflammatory Disease, WH Freeman, New York, NY, 1992, pp 83-115.
24. Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 70:427-51(1990).
25. Meyers CL, Wertheimer SJ, Schembri-King J, Parkas T, Wallace RW: Induction of ICAM-1 by TNF-alpha, IL-1-beta, and LPS in human endothelial cells after downregulation of PKC. Am J Physiol 263:C767-72 (1992).
26. Lo SK, Janakidevi K, Lai L, Malik AB: Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am J Physiol 264:L406-12(1993).
27. Gasic AC, McGuire G, Krater S, Farhood AI, Goldstein MA, Smith CW, Entman ML, Taylor AA: Hydrogen peroxide pretreatment of perfused canine vessels induces ICAM-1 and CD18-dependent neutrophil adherence. Circulation 84:2154-66(1991).
28. McFaul SJ, Bowman PD, Ibanez MG, Holt P: The effects of purified hemoglobin solutions on leukocytes and endothelial cells. Biomater Artif Cells Artif Organs 19:436(1991).
29. Feola M, Simoni J, Canizaro PC: Blood Substitute. U.S. Patent No. 5 439 882 (1995).
30. Feola M, Simoni J, Canizaro PC: Polyhemoglobin Stabilized with Purine Derivatives and Glutathione. European Patent No. EP 0 507 870 (1996).
31. Simoni J, Simoni G, Feola M: Chromatographic analysis of biopolymers distribution in "poly-hemoglobin", an intermolecularly crosslinked hemoglobin solution. Anal Chim Acta 279:73-88(1993).
32. Feola M, Simoni J, Canizaro PC: Quality control of hemoglobin solutions: I. the purity of hemoglobin before modification. Artif Organs 15:234-278(1991).
33. Simoni J, Simoni G, Feola M, Canizaro PC: Evaluation of anion-exchange liquid chromatography for purification of hemoglobin from peptides and other proteins. Anal Chim Acta 249:169-83(1991).
34. Winterbourn CC: Reactions of Superoxide with hemoglobin, in Greenwald RA, (ed), Handbook of Methods for Oxygen Radicals Research, Boca Raton, FL, CRC Press, 1985, pp 137-41.
35. Yoshida Y, Kashiba K, Niki E: Free radical mediated oxidation of lipids induced by hemoglobin in aqueous dispersions. Biochim Biophys Acta 1201:165-72(1994).
36. 2+ in oxidant-induced NF-kappa B activation. FEBS Lett 385:58-62(1996)
37. Pahl HL, Baeuerie PA: Oxygen and the control of gene expression. BioEssays 16:497-502(1994).
38. Anadalibi A, Liao F, Imes S, Fogelman AM, Lusis AJ: Oxidized lipoproteins influence gene expression by causing oxidanve stress and activating the transcription factor NF-kappa B. Biochem Soc Trans 21:651-655(1993).
39. Schreck R, Albermann K, Baeuerle PA: Nuclear factor kappa B: an oxidative stress responsive transcription factor of eukaryotic cells. Free Rad Res Commun 17:221-37(1992).
40. Kwak EL, Larochelle DA, Beaumont C, Toni FM: Role of NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha. J Biol Chem 270:15285-93(1995).
41. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG: Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human oxygenase 1 gene. Proc Natl Acad Sci USA 91:5987-91(1994).
42. Kutty RK, Daniel RF, Ryan DE, Levin W, Maines MD: Rat liver cytochrome P-450b, P-420b, and P-420c are degraded to biliverdin by heme oxygenase. Arch Biochem Biophys 260:638-44(1988).
43. White KA, Marletta MA: Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 31:6627-31(1992).
44. Crow JP, Spruell C, Chen J, Gunn C, Ischiropoulos H, Tsai M, Smith CD, Radi R, Koppenol WH, Beckman JS: On the pH-dependent yield of hydroxyl radical products from peroxynitrite. Free Rad Biol Med 16:331-8(1994).
45. Volk T, Ioannidis I, Hensel M, deGroot H, Kox WJ: Endothelial damage induced by nitric oxide: synergism with reactive oxygen species. Biochem Biophys Res Commun 213:196-203(1995).
46. Jia L, Bonaventura C, Bonaventura J, Stamler JS: S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380:221-6(1996).
47. G-nitro-L-arginine improves myocardial function following ischemia/reperfusion in isolated perfused rat heart. J Mol Cell Cardiol 27:419-26(1995).
48. Edwing JF, Raju VS, Maines MD: Induction of heart heme oxygenase-1 (HSP32) by hyperthermia: possible role in stress-mediated elevation of cyclic 3′,5′-guanosine monophosphate. J Pharmacol Exp Therap 271:408-14(1994).
49. Morita T, Perrella MA, Lee M, Kourembanas S: Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92:1475-9(1995).
50. Johnson RA, Lavesa M, Askari B, Abraham NG, Nasjletti A: A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension 25:166-9(1995).
51. Grimm S, Baeuerle PA: The inducible transcription factor NF-kappa B: structure-function relationship of its protein subunits. Biochem J 290:297-308(1993).
52. Collins T: Endothelial nuclear factor-kappa B and the initiation of the artheriosclerotic lesion. Lab Invest 68:499-508(1993).
53. Osborn L, Lobb R: Direct-expression cloning of endothelial adhesion molecules. In: Gordon JL (ed) Vascular Endothelium Interactions with Circulating Cells, Amsterdam, London, New York, Tokyo, Elsevier Science Publisher B. V., 1991 pp 45-58.
54. Ewenstein BM, Jacobson BC, Brich KA: Regulated secretion in vascular endothelium. In: Wong PY-K, Sehran CN (eds). Cell-Cell Interactions in the Release of Inflammatory Mediators, New York, NY, Plenum Press, 1991, pp 141-157.
55. Luscinskas FW, Lawler J: Integrins as a dynamic regulator of vascular function. FASEB J 8:929-938(1994)
56. Simoni J, Simoni G, Lox CD, Prien SD, Shires GT: Modified Hb solution, with low prooxidant potential and desired pharmacological and anti-inflammatory properties, does not activate the transcription factor NF-kappa B in human vascular endothelial cells. Artif Cells Blood Substit Immobil Biotechnol 24:429(1996).
57. i elevation induced by erythrocyte components in endothelial cells. J Phramacol Exp Ther 277:1501-1509(1996).
58. Feola M, Simoni J, Angelillo R, Luhruma Z, Kabakele M, Manzobi M, Kaluila M: Clinical trial of a hemoglobin based blood substitute in patients with sickle cell anemia. Surg Gynecol Obstet 174:379-86(1992).
59. Simoni J, Simoni G, Newman G, Feola M: An improved blood substitute: in vivo evaluation of its hemodynamic effects. ASAIO Journal 42:M773-M782(1996).
60. Daval JL, Nehling A, Nicolas F: Physiological and pharmacological properties of adenosine: therapeutic implications. Life Sci 49:1435-53(1991).
61. Cronstein BN: Adenosine, an endogenous anti-inflammatory agent. J Appl Physiol 76:5-13(1994).
62. Maggirwar SB, Dhanraj DN, Somani SM, Ramkumar V: Adenosine acts as an endogenous activator of the cellular antioxidant defense system. Biochem Biophys Res Commun 201:508-15(1994).
63. Bouma MG, Stad RK, van der Wildenberg FAJM, Buurman WA: Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J Immunol 153:4159-68(1994).
64. Bouma MG, van der Wildenberg FAJM, Buurman WA: Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am J Physiol 270:C522-9(1996).
65. Adkins WK, Barnard JW, May S, Siebert AF, Haynes J, Taylor AE: Compounds that increase cAMP prevent ischemia-reperfusion pulmonary capilary injury. J Appl Physiol 72:492-7(1992).
66. Morandini R, Ghanem G, Portier-Lemarie A, Robaye B, Renaud A, Boeynaerns JM: Action of cAMP on expression and release of adhesion molecules in human endothelial cells. Am J Physiol 270:H807 -H816(1996).
67. Ghersa P, van Huijsduijnen RH, Whelan J, Cambert Y, Pescini R, DeLamarter JF: Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J Biol Chem 269:29129-37(1994).
68. 2+ by cAMP in vascular smooth muscle cells. Am J Physiol 258:C300-407(1990).
69. Grisham MB, Hernandez LA, Granger DN: Adenosine inhibits ischemia-reperfusion-induced leukocyte adherence and extravasation. Am J Physiol 257:H1334-9(1989).